Eidos治疗
EIDX

From June 30, 2020 to September 30, 2020 Issuance of common stock upon exercise of stock options

From March 31, 2020 to June 30, 2020 Issuance of common stock upon exercise of stock options Issuance of common stock under employee stock plans

From December 31, 2019 to March 31, 2020 Issuance of common stock upon exercise of stock options and restricted stock Issuance of common stock in at-the-market offering, net offering cost of $24

from December 31, 2018 to December 31, 2019 Issuance of common stock under employee stock plans Issuance of common stock upon exercise of stock options and restricted stock Issuance of common stock to Alexion Pharmaceuticals, Inc. Issuance of common stock in at-the-market offering, net of offering costs of $48

from June 30, 2019 to September 30, 2019 Issuance of common stock upon exercise of stock options and restricted stock Issuance of common stock under Alexion stock purchase agreement

from March 31, 2019 to June 30,2019 Issuance of common stock upon exercise of stock options and restricted stock Issuance of common stock under employee stock plans

from December 31, 2018 to March 31, 2019 Issuance of common stock upon exercise of stock options and restricted stock

from December 31, 2017 to December 31, 2018 Issuance of Series B redeemable convertible preferred stock, net of issuance costs of $125 and fair value of redeemable convertible preferred stock tranche liability of $64 Issuance of Series B redeemable convertible preferred stock, net of issuance costs of $0 Issuance of Series B redeemable convertible preferred stock upon conversion of redeemable convertible promissory notes payable to stockholders Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering Issuance of common stock to Stanford University Issuance of common stock upon exercise of stock options and restricted stock Issuance of common stock under employee stock plans Net exercise of redeemable convertible preferred stock warrant liability Issuance of common stock upon initial public offering, net of issuance costs Repurchase of early exercised stock options

1. Common stock offered 6,250,000 shares 2. The number of shares of common stock to be outstanding after this offering is based on 5,333,010 shares of common stock outstanding as of March 31, 2018 3. A 1.196 for 1 split of our outstanding shares of common stock effected on June 7, 2018

from December 31, 2016 to December 31, 2017 Issuance of Series Seed redeemable convertible preferred stock, net of issuance costs of $7 Issuance of common stock to Stanford University in exchange for services and technology Issuance of restricted common stock to founders in connection with anti-dilution rights Issuance of common stock upon exercise of stock options and restricted stock